New study: can a special multivitamin boost health after childbirth?
NCT ID NCT07303595
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a daily multivitamin designed for women after childbirth can improve their nutrient levels and overall wellbeing. Eighty healthy new mothers (within 6 weeks of giving birth) will take either the supplement or a placebo for 12 weeks. Researchers will measure blood nutrient levels, mental health, and other health markers to see if the supplement makes a difference.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Perelel Mom Multi (postnatal multivitamin and mineral supplement)
- What this could lead to
- If it works, this could show that a tailored multivitamin helps new mothers restore key nutrients and feel better after childbirth.
- What could go wrong
- This is a small, early-stage trial with only 80 participants. The supplement may not significantly improve nutrient levels or wellbeing compared to placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2025
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: * Healthy, postpartum women (\~4 weeks \[± 2 weeks\]) with infants born term and singleton * Not pregnant during the study period * Able to understand (written and spoken) English or Spanish. Exclusion criteria: * Cardiometabolic disease * Past pregnancy complications (gestational diabetes, hypertension) * malabsorption syndromes (IBS, IBD, Crohn's, Colitis, Celiac) * Caily use of medications which may affect nutrient absorption * chronic alcohol use (\> 4 alcoholic drinks/day) * those prescribed postnatal MVM supplements by their physician * unwilling to discontinue dietary supplementation containing any of the active components in the study product over the study period * Women should not have an allergy or intolerance to active or inactive product ingredients.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Postnatal care are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
UGA Clinical & Translational Unit
RECRUITINGAthens, Georgia, 30606, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.